ProfileGDS4132 / 209664_x_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 35% 37% 37% 42% 36% 42% 34% 35% 41% 38% 40% 45% 40% 46% 35% 38% 34% 33% 40% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10187.47235
GSM201543Muscle PCOS pioglitazone 12185.681937
GSM201544Muscle PCOS pioglitazone 16197.806337
GSM201545Muscle PCOS pioglitazone 201118.71342
GSM201829Muscle PCOS pioglitazone 23196.473236
GSM201830Muscle PCOS pioglitazon 251112.28342
GSM201831Muscle PCOS pioglitazone 27184.885634
GSM201832Muscle PCOS pioglitazone 3188.851935
GSM201833Muscle PCOS pioglitazone 4199.829441
GSM201834Muscle PCOS pioglitazone 8194.541138
GSM201835Muscle PCOS after pioglitazone 10288.134240
GSM201836Muscle PCOS after pioglitazone 122108.59645
GSM201837Muscle PCOS after pioglitazone 16289.05140
GSM201838Muscle PCOS after pioglitazone 202111.86146
GSM201839Muscle PCOS after pioglitazone 23280.876335
GSM201840Muscle PCOS after pioglitazone 25292.157638
GSM201841Muscle PCOS after pioglitazone 27270.108734
GSM201842Muscle PCOS after pioglitazone 3266.097233
GSM201843Muscle PCOS after pioglitazone 4298.916240
GSM201844Muscle PCOS after pioglitazone 8290.947238